Top compounds associated with response to SMAD4


Feature Type Standardized
Nominal ANOVA
mRNA prima-1 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.2 4e-07
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 5e-07
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.15 6e-07
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.2 6e-07
Download CSV